The adequacy of measurement of short and long-term consequences of false-positive screening mammography

Journal of Medical Screening

Volumn 11, Issue 1, 2004, Pages 39-44

  Brodersen, John ^a,b   Thorsen, Hanne ^b   Cockburn, Jill ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; DATA ANALYSIS; DATA BASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENERAL HEALTH QUESTIONNAIRE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAMMOGRAPHY; PSYCHOLOGICAL CONSEQUENCES QUESTIONNAIRE; PSYCHOMETRY; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RATING SCALE; REVIEW; STATE TRAIT ANXIETY INVENTORY;

ANXIETY; DATABASES, BIBLIOGRAPHIC; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MAMMOGRAPHY; MEDLINE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 1642368843     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1258/096914104772950745     Document Type: Review

References (81)

1. Mushlin AI, Kouides RW, Shapiro DE. Estimating the accuracy of screening mammography: a meta-analysis. Am J Prev Med 1998;14:143-53.
2. Ward J. Population-based mammographic screening: does 'informed choice' require any less than full disclosure to individuals of benefits, harms, limitations and consequences?. Aust N Z J Public Health 1999;23:301-4.
3. Department of Health. NHS Cancer Screening Programmes. Breast screening programme 2000-2001. Available from: http://www.doh.gov.uk/public/sb0201.htm (last accessed 30 December 2003).
4. Bode M, Eckhardt S, Fitzpatrick R, et al. Consultation on psychological implications of mass screening for cancer. Report on a WHO meeting. Salgobanya, Hungary, 20-21 September. Copenhagen: World Health Organization, Regional Office for Europe, 1990.
5. Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: World Health Organization, 1968.
6. Gray JA, Austoker J. Quality assurance in screening programmes. Br Med Bull 1998;54:983-92.
7. Tabor A, Hornnes PJ, Ottesen BS. [UL-scanning for ovarian cancer]. Ugeskr Laeger 1997;159:1461-3 (in Danish).
8. Anonymous. Kræft i tyktarm og endetarm. Diagnostik og screening. [Cancer of the colon and rectum. Diagnosis and screening.] Copenhagen: Statens Institut for Medicinsk Teknologivurdering [Danish Institute for Health Technology Assessment], 2001 (in Danish). Available from: http://www.cemtv.dk/ publikationer/docs/Kolorektal/marts2001/pdf/kolorektal1-38.pdf (last accessed 30 December 2003).
9. Manser RL, Irving LB, Stone C, Byrnes G, Abramson M, Campbell D. Screening for lung cancer. Cochrane Database Syst Rev 2001;3:CD001991.
10. Weil JG, Hawker JI. Positive findings of mammography may lead to suicide. BMJ 1997;314:754-5.
11. Mant D, Fowler G. Mass screening: theory and ethics. BMJ 1990;300:916-8.
12. Ellman R, Angeli N, Christians A, et al. Psychiatric morbidity associated with screening for breast cancer. Br J Cancer 1989;60:781-4.
13. Gram IT, Lund E, Slenker SE. Quality of life following a false positive mammogram. British Journal of Cancer 1990;62:1018-22.
14. Bull AR, Campbell MJ. Assessment of the psychological impact of a breast screening programme. Br J Radiol 1991;64:510-5.
15. Lerman C, Trock B, Rimer BK, et al. Psychological side effects of breast cancer screening. Health Psychology 1991;10:259-67.
16. Lerman C, Trock B, Rimer BK, et al. Psychological and behavioral implications of abnormal mammograms. Ann Intern Med 1991;114:657-61.
17. Gram IT, Slenker SE. Cancer anxiety and attitudes toward mammography among screening attenders, nonattenders, and women never invited. Am J Public Health 1992;82:249-51.
18. Cockburn J, Staples M, Hurley SF, De LT. Psychological consequences of screening mammography. J Med Screen 1994;1:7-12.
19. Lidbrink E, Levi L, Pettersson I, et al. Single-view screening mammography: psychological, endocrine and immunological effects of recalling for a complete three-view examination. Eur J Cancer 1995;31A:932-3.
20. Sutton S, Saidi G, Bickler G, Hunter J. Does routine screening for breast cancer raise anxiety? Results from a three wave prospective study in England. J Epidemiol Community Health 1995;49:413-8.
21. Chen CC, David A, Thompson K, et al. Coping strategies and psychiatric morbidity in women attending breast assessment clinics. J Psychosom Res 1996;40:265-70.
22. Swanson V, McIntosh IB, Power KG, Dobson H. The psychological effects of breast screening in terms of patients' perceived health anxieties. Br J Clin Pract 1996;50:129-35.
23. Ong G, Austoker J, Brett J. Breast screening: adverse psychological consequences one month after placing women on early recall because of a diagnostic uncertainty. A multicentre study. J Med Screen 1997;4:158-68.
24. Scaf-Klomp W, Sanderman R, van der Wiel HB, et al. Distressed or relieved? Psychological side effects of breast cancer screening in The Netherlands. J Epidemiol Community Health 1997;51:705-10.
25. Brett J, Austoker J, Ong G. Do women who undergo further investigation for breast screening suffer adverse psychological consequences? A multicentre follow-up study comparing different breast screening result groups five months after their last breast screening appointment. J Public Health Med 1998;20:396-403.
26. Gilbert FJ, Cordiner CM, Affleck IR, et al. Breast screening: the psychological sequelae of false-positive recall in women with and without a family history of breast cancer. Eur J Cancer 1998;34:2010-4.
27. Lowe JB, Balanda KP, Del MC, Hawes E. Psychologic distress in women with abnormal findings in mass mammography screening. Cancer 1999;85:1114-8.
28. Olsson P, Armelius K, Nordahl G, et al. Women with false positive screening mammograms: how do they cope? J Med Screen 1999;6:89-93.
29. Aro AR, Pilvikki Absetz S, van Elderen TM, et al. False-positive findings in mammography screening induces short-term distress - breast cancer-specific concern prevails longer. Eur J Cancer 2000;36:1089-97.
30. Lipkus IM, Halabi S, Strigo TS, Rimer BK. The impact of abnormal mammograms on psychosocial outcomes and subsequent screening. Psychooncology. 2000;9:402-10.
31. Brett J, Austoker J. Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance. J Public Health Med 2001;23:292-300.
32. Ekeberg O, Skjauff H, Karesen R. Screening for breast cancer is associated with a low degree of psychological distress. Breast 2001;10(1):20-24.
33. Lampic C, Thurfjell E, Bergh J, Sjoden PO. Short-and long-term anxiety and depression in women recalled after breast cancer screening. Eur J Cancer 2001;37:463-9.
34. Lindfars KK, O'Cannar J, Parker RA. False-positive screening mammagrams: effect of immediate versus later wark-up an patient stress. Radiology 2001;218:247-53.
35. Meystre-Agustoni G, Paccaud F, Jeannin A, Dubois-Arber F. Anxiety in a cohort of Swiss women participating in a mammographic screening programme. J Med Screen 2001;8:213-9.
36. Hislop TG, Harris SR, Jackson J, et al. Satisfaction and anxiety for women during investigation of an abnormal screening mammogram. Breast Cancer Res Treat 2002;76:245-54.
37. Sandin B, Chorot P, Valiente RM, et al. Adverse psychological effects in women attending a second-stage breast cancer screening. J Psychosom Res 2002;52:303-9.
38. Bowland L, Cockburn J, Cawson J, et al. Counselling interventions to address the psychological consequences of screening mammography: a randomised trial. Patient Educ Couns 2003;189-98.
39. Rimer BK, Bluman LG. The psychosocial consequences of mammography. J Nat Cancer Inst Monographs 1997;22:131-8.
40. Steggles S, Lightfoat N, Sellick SM. Psychological distress associated with organized breast cancer screening. Cancer Prev Control 1998:2:213-20.
41. von Bulow B. [Psychological consequences of breast cancer screening among healthy women] (in Danish). Ugeskrift for Laeger 2000;162:1053-9.
42. Dean C, Roberts MM, French K, Robinson S. Psychiatric morbidity after screening for breast cancer. J Epidemiol Community Health 1986;40:71-5.
43. Elkind A, Eardley A. Consumer satisfaction with breast screening: a pilot study. J Public Health Med 1990;12:15-8.
44. Lightfoot N, Steggles S, Wilkinson D, et al. The short-term psychological impact of organised breast cancer screening. Current Oncology (Toronto, 1198-0052) 1994;1:206-11.
45. Walker LG, Cordiner CM, Gilbert FJ, et al. How distressing is attendance for routine breast screening? Psychooncology 1994;3:299-304.
46. Ong G, Austoker J. Recalling women for further investigation of breast screening: women's experiences at the clinic and afterwards. J Public Health Med 1997;19:29-36.
47. Olsson P, Armelius K, Lenner P, Westman G. [Mammography screening. A pilot study of the psychological effects] (in Swedish). Lakartidningen 1990;90:3213-4.
48. Bartolucci G, Savron G, Fava GA, et al. Psychological reactions to thermography and mammography. Stress Med 1989;5:195-9.
49. Lunde IM. "Jeg håber det bedste..." ["I hope for the best..."] (in Danish). Ringkøbing: Den Medicinske Forskningsenhed [Ringkøbing Medical Research Unit], Ringkøbing, 1997.
50. Padgett DK, Yedidia MJ, Kerner J, Mandelblatt J. The emotional consequences of false positive mammography: African-American women's reactions in their own words. Women Health 2001;33:1-14.
51. Goldberg D. The Detection of Psychiatric Illness be questionnaire. Oxford: Oxford University Press, 1972.
52. Veroff J, Feld S, Gurin G. Dimensions of subjective adjustment. J Abnorm Soc Psychol 1962;64:192-205.
53. Abramson JH, Terespolsky L, Brook JG, Kark SL. Cornell Medical Index as a health measure in epidemiological studies. A test of the validity of a health questionnaire. Brit J Prev Soc Med 1965;19:103-10.
54. Brodman K, Erdmann AJ, Wolff HG. Cornell Medical Index Health Questionnaire (Manual). New York: Cornell University Medical College, 1956.
55. Fried M, Lindemann E. Socio-cultural factors in mental health and illness. Am J Orthopsychiatry 1961;1:87-95.
56. Streiner DL, Norman GR. Health measurement scales: A practical guide to their development and use. Oxford: Oxford University Press, 1995.
57. Goldberg D. Manual of the General Health Questionnaire. Horsham: NFER Publishing Company, 1978.
58. Goldberg D, Williams P. A user's guide to the General Health Questionnaire. London: NFER-Nelson, 1988.
59. Duncan-Jones P, Grayson DA, Moran PA. The utility of latent trait models in psychiatric epidemiology. Psychol Med 1986;16:391-405.
60. Andrich D, van Schoubroeck L. The General Health Questionnaire: a psychometric analysis using latent trait theory. Psychol Med 1989;19:469-85.
61. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70.
62. Klein DF. Endogenomorphic depression. A conceptual and terminological revision. Arch Gen Psychiatry 1974;31:447-54.
63. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:20-55.
64. Snaith RP, Baugh SJ, Clayden AD, et al. The Clinical Anxiety Scale: an instrument derived from the Hamilton Anxiety Scale. Br J Psychiatry 1982;141:518-23.
65. Wing JK, Cooper JE, Sartorius N. The measurement and classification of psychiatric symptoms. Cambridge: Cambridge University Press, 1974.
66. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale - a review of validation data and clinical results. J Psychosom Res 1997;42:17-41.
67. Cockburn J, De Luise T, Hurley S, Clover K. Development and validation of the PCQ: a questionnaire to measure the psychological consequences of screening mammography. Soc Sci Med 1992;34:1129-34.
68. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Medical Care 1981;19:787-805.
69. Irwig L, Cackburn J, Turnbull D, et al. Women's perceptions of screening mammography. Aust J Public Health 1991;15:24-32.
70. Selby PJ, Chapman JA, Etazadi-Amoli J, et al. The development of a method for assessing the quality of life of cancer patients. Br J Cancer 1984;50:13-22.
71. Schipper H, Clinch J, McMurray A, Levitt M. Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation. J Clin Oncol 1984;2:472-83.
72. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory. Palo Alto, California: Consulting Psychologists Press, 1970.
73. Welsh GS. Factor dimensions A and R. In: Welsh GS, Dahlstrom WG, eds. Basic readings on the MMPI in Psychology and Medicine. Minneapolis: University of Minnesota Press, 1956: 264-81.
74. Taylor JA. A personality scale of manifest anxiety. J Abnorm Soc Psychol 1953;48:285-90.
75. Cattell RB, Scheier IH. Handbook far the IPAT Anxiety Scale. Champaign, Illinois: Institute far Personality and Ability Testing, 1963.
76. Spielberger CD, Vagg PR, Barker LR, et al. The Factor Structure of the State-Trait Anxiety Inventory. In: Sarason IG, Spielberger CD, eds. Stress and Anxiety. New York: Hemisphere Publishing Corporation, 1980: 95-109.
77. Spielberger CD, Gorsuch RL, Lushene RE, et al. Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto, California: Consulting Psychologists Press, 1983.
78. Tenenbaum G, Furst D, Weingarten G. A statistical re-evaluation of the STAI anxiety questionnaire. J Clin Psychol 1985;41:239-44.
79. Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). BrJ Clin Psychol 1992;31:301-6.
80. Baines CJ, To T, Wall C. Women's attitudes to screening after participation in the National Breast Screening Study. A questionnaire survey. Cancer 1990;65:1663-9.
81. Thiis-Evensen E, Wilhelmsen I, Hoff GS, et al. The psychologic effect of attending a screening program for colorectal polyps. Scand J Gastroenterol 1999;34:103-9.